FR2258181A1 - - Google Patents

Info

Publication number
FR2258181A1
FR2258181A1 FR7412992A FR7412992A FR2258181A1 FR 2258181 A1 FR2258181 A1 FR 2258181A1 FR 7412992 A FR7412992 A FR 7412992A FR 7412992 A FR7412992 A FR 7412992A FR 2258181 A1 FR2258181 A1 FR 2258181A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7412992A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of FR2258181A1 publication Critical patent/FR2258181A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02Lithium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FR7412992A 1974-03-14 1974-04-12 Withdrawn FR2258181A1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US451195A US3897442A (en) 1974-03-14 1974-03-14 Thiazole cardiovascular agents
US451194A US3896139A (en) 1974-03-14 1974-03-14 Process for preparing 3-(4-or-5-azidocarbonylthiazol-2-oxy)-propanediol-1,2-acetonides

Publications (1)

Publication Number Publication Date
FR2258181A1 true FR2258181A1 (enExample) 1975-08-18

Family

ID=27036271

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7409755A Withdrawn FR2278336A2 (fr) 1974-03-14 1974-03-21 Agents cardiovasculaires a base de thiazoles
FR7412992A Withdrawn FR2258181A1 (enExample) 1974-03-14 1974-04-12

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7409755A Withdrawn FR2278336A2 (fr) 1974-03-14 1974-03-21 Agents cardiovasculaires a base de thiazoles

Country Status (9)

Country Link
US (2) US3896139A (enExample)
JP (2) JPS50123673A (enExample)
AU (1) AU6693674A (enExample)
BE (2) BE812689R (enExample)
DE (2) DE2414038A1 (enExample)
FR (2) FR2278336A2 (enExample)
GB (2) GB1461173A (enExample)
NL (2) NL7403855A (enExample)
SE (1) SE7406677L (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064259A (en) * 1976-07-19 1977-12-20 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
US4119718A (en) * 1977-05-02 1978-10-10 Merck & Co., Inc. 3-Amino-2-oxy-propoxy-substituted isothiazoles
US4259341A (en) * 1977-06-01 1981-03-31 Merck & Co., Inc. Di- and tri-substituted thiazoles
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
DE3718765A1 (de) * 1986-06-11 1987-12-17 Nippon Shinyaku Co Ltd Benzoesaeurederivate
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
AU2003270562B2 (en) * 2002-09-12 2010-09-16 Diakron Pharmaceuticals, Inc. Calcium channel blockers
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
US20110305751A1 (en) 2009-02-20 2011-12-15 To-Bbb Holding B.V. Glutathione-based drug delivery system
AU2010245823B2 (en) 2009-05-06 2016-11-24 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1047927A (en) * 1964-03-09 1966-11-09 Ici Ltd Alkanolamine derivatives
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
DE1795106B2 (de) * 1968-08-10 1976-04-29 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2- brom- oder chlor-5-nitrothiazol

Also Published As

Publication number Publication date
AU6776674A (en) 1975-10-16
GB1461173A (en) 1977-01-13
NL7405599A (nl) 1975-09-16
SE7406677L (sv) 1975-09-15
DE2414038A1 (de) 1975-10-09
BE815388A (fr) 1974-11-22
AU6693674A (en) 1975-09-25
NL7403855A (nl) 1975-09-16
US3897442A (en) 1975-07-29
JPS50123671A (enExample) 1975-09-29
FR2278336A2 (fr) 1976-02-13
GB1455945A (en) 1976-11-17
DE2416016A1 (de) 1975-09-25
US3896139A (en) 1975-07-22
BE812689R (fr) 1974-09-23
JPS50123673A (enExample) 1975-09-29

Similar Documents

Publication Publication Date Title
AU465373B2 (enExample)
AR199134A1 (enExample)
AU1893276A (enExample)
AR197698Q (enExample)
CS171040B1 (enExample)
BE829579A (enExample)
AU481917A (enExample)
AU479427A (enExample)
AU479523A (enExample)
AU479624A (enExample)
AU479870A (enExample)
AU480070A (enExample)
AU480148A (enExample)
AU480401A (enExample)
AU480465A (enExample)
AU480559A (enExample)
AU480783A (enExample)
AU480879A (enExample)
BG19548A2 (enExample)
AU481360A (enExample)
BG19488A1 (enExample)
AU482244A (enExample)
AU482365A (enExample)
BE525532A (enExample)
BG19990A1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse